
Laxmi Organic Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- Laxmi Organic aims to double revenues from FY'24 to FY'28.
- Plans to triple EBITDA in the same period.
- Ambition to double ROCE from 10% in FY'24 to 20% in FY'28.
- Volume growth target of 1.75x from a base of 234 kt achieved in FY'24 for Essentials segment.
- Specialty segment to see growth with 20% of sales coming from products launched in the last 5 years.
- Dahej facility commercial revenues expected to start in FY'26 and peak by FY'28, doubling capacity for Ketene and Diketene products.
- Capex of INR1,100 crores planned from FY'24 to FY'28 to support growth.
- Expansion in market share, product portfolio, exports, and entry into new segments, especially fluoro in specialties.
- Continued focus on operational excellence and cost leadership to propel growth.
See what Laxmi Organic management said on margin guidance — free account, 30 seconds.
Fundraise plans
- The transcript does not mention any current or planned fundraising through debt or equity.
- The company highlights having an unleveraged balance sheet, indicating no current debt burden.
- Emphasis is placed on capacity expansions funded through internal capex plans totaling INR1,100 crores from FY'24 to FY'28.
- Capex is planned for both Essentials (INR550 crores) and Specialties (incremental INR550 crores) segments.
- No references to raising funds externally were made; the company appears to rely on its strong balance sheet and operational cash flow to fund growth.
- The focus remains on doubling revenues, tripling EBITDA, and doubling ROCE by FY'28 through internal resources and strategic capex rather than external fundraising.
See what Laxmi Organic management said on order book — free account, 30 seconds.
Capex plans
Yes- INR 1,100 crores capex planned between FY'24 to FY'28.
- Ambition to double revenues from FY'24, triple EBITDA, and double ROCE from 10% (FY'24) to 20% (FY'28).
- INR 550 crores capex in Essentials segment over FY'25 and FY'26 to expand and diversify product portfolio.
- INR 400 crores capex for Specialties from FY'25 to FY'26 and INR 150 crores from FY'26 to FY'28 for expanding and optimizing portfolio, including doubling Ketene and Diketene capacities at Dahej.
- Dahej facility civil foundation work started; revenues expected from FY'26 with peak in FY'28.
- Lote site has capacity for an additional INR 500 crores capex.
- Focus on new products with 20% of specialty revenues from products launched in last 5 years.
- Strategic investments in technology, bio-based products, and portfolio expansion especially in fluoro segment.
Track Laxmi Organic — get its next earnings analysis in your feed
How does Laxmi Organic rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Laxmi Organic rank in Chemicals & Petrochemicals?
Compare Laxmi Organic against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Laxmi Organic's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…